Megavoltage Radiosensitization of Gold Nanoparticles on Glioblastoma Cancer Cell Line Using a Clinical Platform

Abstract

Megavoltage radiosensitization of gold nanoparticles on glioblastoma cancer cell line using a clinical platform Farasat Kazmi, Katherine A Vallis, Balamurugan A Vellayappan, Aishwarya Bandla, Duan Yukun, Robert Carlisle Affiliations: 1. Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, United Kingdom. 2. CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, United Kingdom. 3. Department of Radiation Oncology, National University Cancer Institute (NCIS), Singapore. 4. Singapore Institute for Neurotechnology (SINAPSE), National University of Singapore (NUS), Singapore. 5. Department of Chemical and Biomolecular Engineering, National University of Singapore (NUS), Singapore 6. Department of Biomedical Engineering, University of Oxford, United Kingdom.